top of page
For Physicians
For Patients
About
Company
Rivermark AU
News
Contact Us
Rivermark
News
Andera Partners Leads $20 MillionSeries D Financing in RivermarkMedical.
RIVERMARK MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN RAPID III CLINICAL STUDY EVALUATING THE FLOSTENT® SYSTEM
Rivermark Medical Closes $30 Million Series C Financing to Advance Development of FLOSTENT™ System for Benign Prostatic Hyperplasia
Rivermark Medical Announces Completion of Expanded Indication Study for the Flostent System
Rivermark Medical Announces Fully Enrolled Multi-center OUS Clinical Trial for Innovative Benign Prostatic Hyperplasia Device
Rivermark Medical announces successful first-in-human use of its Flostent System For Symptomatic BPH
bottom of page
